VERU Stock Analysis: Buy, Sell, or Hold?
VERU - Veru Inc.
$2.53
-0.08 (-3.07%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 12, 2026
12d
Get Alerted When VERU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VERU shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VERU shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VERU is currently trading at $2.53, which is considered slightly high relative to its 30-day fair value range of $2.25 to $2.61.
Technical Outlook: Technically, VERU is in a strong downtrend. Immediate support is located at $2.38, while resistance sits at $2.84. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: VERU has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $18.00 (+589.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VERU is in a strong downtrend. Immediate support is located at $2.38, while resistance sits at $2.84. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: VERU has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $18.00 (+589.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$2.25 -
$2.61
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.2%
Protect Your Profits
Holding VERU? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 589.7% below Wall St target ($18.00)
- CAUTION: Recommendation downgraded due to -9.6% 5-day decline
Fair Price Analysis
30-Day Fair Range
$2.25 -
$2.61
Current vs Fair Value
SLIGHTLY HIGH
Expected Move (7 Days)
±$0.26
(10.3%)
Support & Resistance Levels
Support Level
$2.38
Resistance Level
$2.84
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.52
Wall Street Target
$18.00
(+589.7%)
Revenue Growth (YoY)
18.3%
Last updated: January 30, 2026 5:41 PM ET
Data refreshes hourly during market hours. Next update: 6:41 PM
Data refreshes hourly during market hours. Next update: 6:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VERU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$85 | 55 HOLD |
Advanced VERU Option Strategies
Professional options setups generated by AI based on today's VERU price and gamma walls.
